切换至 "中华医学电子期刊资源库"

中华胃食管反流病电子杂志 ›› 2022, Vol. 09 ›› Issue (01) : 35 -38. doi: 10.3877/cma.j.issn.2095-8765.2022.01.007

综述

2型糖尿病与胃食管反流病的相关性研究进展
迪丽达尔·阿迪里1, 买买提·依斯热依力2, 艾克拜尔·艾力3,()   
  1. 1. 830054 乌鲁木齐,新疆医科大学研究生学院
    2. 830001 乌鲁木齐,新疆维吾尔自治区人民医院微创,疝和腹壁外科;830001 乌鲁木齐,新疆维吾尔自治区人民医院自治区普外微创研究所;830001 乌鲁木齐,新疆维吾尔自治区胃食管反流病及减重代谢外科临床研究中心
    3. 830054 乌鲁木齐,新疆医科大学研究生学院;830001 乌鲁木齐,新疆维吾尔自治区人民医院微创,疝和腹壁外科;830001 乌鲁木齐,新疆维吾尔自治区人民医院自治区普外微创研究所;830001 乌鲁木齐,新疆维吾尔自治区胃食管反流病及减重代谢外科临床研究中心
  • 收稿日期:2021-05-12 出版日期:2022-02-15
  • 通信作者: 艾克拜尔·艾力
  • 基金资助:
    国家自然科学基金项目(82060166); 新疆维吾尔自治区引进高层次人才天池百人计划项目(201939); 新疆维吾尔自治区自然科学基金(2021D01C148)

Research progress of correlation between type 2 diabetes mellitus and gastroesophageal reflux disease

Dilidaer·Adili1, Maimaiti·Yisireyili2, Aikebaier·Aili3,()   

  1. 1. Xinjiang Medical University Graduate School of Medicine, Urumqi 830054, China
    2. Department of Minimally Invasive Surgery, Hernia and Abdominal Wall Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China; Research Institute of General and Minimally Invasive Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China; Xinjiang Uygur Autonomous Region Gastroesophageal Reflux Disease and Weight Loss Metabolism Surgery Clinical Research Center, Urumqi 830001, China
    3. Xinjiang Medical University Graduate School of Medicine, Urumqi 830054, China; Department of Minimally Invasive Surgery, Hernia and Abdominal Wall Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China; Research Institute of General and Minimally Invasive Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China; Xinjiang Uygur Autonomous Region Gastroesophageal Reflux Disease and Weight Loss Metabolism Surgery Clinical Research Center, Urumqi 830001, China
  • Received:2021-05-12 Published:2022-02-15
  • Corresponding author: Aikebaier·Aili
引用本文:

迪丽达尔·阿迪里, 买买提·依斯热依力, 艾克拜尔·艾力. 2型糖尿病与胃食管反流病的相关性研究进展[J]. 中华胃食管反流病电子杂志, 2022, 09(01): 35-38.

Dilidaer·Adili, Maimaiti·Yisireyili, Aikebaier·Aili. Research progress of correlation between type 2 diabetes mellitus and gastroesophageal reflux disease[J]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2022, 09(01): 35-38.

2型糖尿病(T2DM)是目前发病率较高的代谢相关疾病,胃食管反流病(GERD)是发病率较高的消化道疾病之一,GERD被认为是T2DM并发症中慢性胃肠道疾病之一。T2DM和GERD的发生发展机制目前尚未研究明确,T2DM并发GERD患者影响食管动力学功能可能与胰岛素抵抗、高血糖、自主神经病变、胃肠激素、一过性下食管括约肌松弛及糖尿病药物使用有关,本文主要以T2DM与GERD相关性研究进展作以总结叙述。

The incidence rate of type 2 diabetes millutes (T2DM) and gastroesophageal reflux disease (GERD) rising in recent years. GERD was thought to be a one of the most chronic gastrointestinal diseases that often occurs in diabetic complications. The mechanism of DM and GERD unclear at present. The influence of esophageal dynamic function in DM complicated with GERD may related to insulin resistance, hyperglycemic autonomic neuropathy, gastrointestinal hormone, transient lower esophageal sphincter relaxation, and diabetic drug use. This article mainly summarizes the research progress of the relationship between DM and GERD.

1
向旭,朱妍,朱海杭. 糖尿病与胃食管反流病临床流行病学研究 [J].胃肠病学和肝病学杂志,2014, 23(3):292-295.
2
Siavash M, Tabbakhian M, Sabzghabaee AM, et a1. Severity of gastrointestinal side effects of metformin tablet compared to met-formin capsule in type 2 diabetes mellitus patients [J]. J Res Pharm Pract,2017, 6(2):73-76.
3
皮尔地瓦斯·麦麦提玉素甫, 艾克拜尔·艾力, 买买提·依斯热依力,等. 减重手术类型与胃食管反流病发病相关性的研究进展[J/OL]. 中华胃食管反流病电子杂志, 2019, 6(3): 161-165.
4
Sawada A, Hashimoto A, Uemura R, et al. Effect of EP1 receptor antagonist on transient lower esophageal sphincter relaxations in humans [J]. Digestion, 2020, 101(3):270-278.
5
魏从光, 魏晓艳, 郝润春. 胃食管反流病的临床研究进展 [J]. 武警医学, 2020, 31(6):88-91.
6
汤浩,丁海蛟. 胃食管反流病发病因素研究 [J].临床军医杂志,2020, 48(6):746-747.
7
Natalini J, Palit A, Sankineni A, et al. Diabetes mellitus is an independent risk for gastroesophageal reflux disease among urban African Americans [J]. Dis Esophagus, 2015, 28(5):405-11.
8
Maev IV, Iurenev GL, Kakhramanova DA. Peculiarities of gastroesophageal reflux disease in patients with type 2 diabetes mellitus [J]. Klinicheskaia Meditsina, 2012, 90(9):53-56.
9
Sirchak YS, Stan MP, Brych VV. Changes in cholecystokinin level in patients with gastroesophageal reflux disease on the background of type II diabetes [J]. Wiad Lek, 2018,71(2 pt 1):333-336.
10
Kellerman R, Kintanar T. Gastroesophageal reflux disease [J]. Prim Care, 2017, 44(4):561-573.
11
Ribolsi M, Balestrieri P, Holloway RH, et al. Intra-bolus pressure and esophago gastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate [J]. Dis Esophagus, 2016, 29(8): 1020-1026.
12
Menezes MA, Herbella FAM. Pathophysiology of gastroesophageal reflux disease [J]. World J Surg, 2017, 41(7):1666-1671.
13
Bou Daher H, Sharara AI. Gastroesophageal reflux disease, obesity and laparoscopic sleeve gastrectomy: the burning questions [J]. World J Gastroenterol, 2019, 25(33): 4805-4813.
14
宋进展, 徐光耀, 周海燕,等. 2型糖尿病患者幽门螺旋杆菌感染情况及胃肠病变特点 [J]. 临床医学研究与实践, 2019, 4(14):52-54.
15
Gyawali CP, Fass R. Management of gastroesophageal reflux Disease [J]. Gastroenterology, 2018, 154(2):302-318.
16
Brandt SJ, Götz A, Tschöp MH, Müller TD. Gut hormone polyagonists for the treatment of type 2 diabetes [J]. Peptides, 2018, 100:190-201
17
张亚萍, 高革, 张宽学,等. 糖尿病胃肠功能紊乱模型胃肠道超微结构变化的研究 [J]. 临床消化病杂志, 2002(4):150-152.
18
伊尔潘江·库尔班, 买买提·依斯热依力, 艾克拜尔·艾力. 肥胖患者腹腔镜袖状胃切除术后并发症的防治研究进展 [J]. 中国医师杂志, 2020, 22(9):1431-1434.
19
Savarino E, de Bortoli N, De Cassan C, et al. The natural history of gastro-esophageal reflux disease: a comprehensive review [J]. Dis Esophagus, 2017, 30(2):1-9.
20
KoichiMuroi, RyojiMiyahara, KoheiFunasaka, et al. Comparison of High-Resolution Manometry in Patients Complaining of Dysphagia among Patients with or without Diabetes Mellitus [J]. Digestion, 2021, 102: 554-562.
21
Monreal-Robles R, Remes-Troche JM. Diabetes and the Esophagus [J]. Curr Treat Options Gastroenterol, 2017, 15(4):475-489.
22
Gokturk S, Akyuz F, Arici S, et al. Gastroesophageal reflux in asymptomatic patients with diabetes: an impedance study diabetes, obesity and gastroesophageal reflux [J]. Exp Clin Endocrinol Diabetes, 2020, 128(1):52-58.
23
乙兵,种新力. 糖尿病大鼠胃肠功能障碍与胃动素、胆囊收缩素、生长激素相关性研究 [J].疾病监测与控制, 2014, 8(12):779-780.
24
Freeman R. Diabetic autonomic neuropathy [J]. Handb Clin Neurol, 2014, 126: 63-79.
25
Liu L, Li S, Zhu K, et al. Relationship between esophageal motility and severity of gastroesophageal reflux disease according to the Los Angeles classification [J]. Medicine (Baltimore), 2019, 98(19):e15543.
26
向旭. 糖尿病与胃食管反流病的相关性研究[D].中南大学, 2014.
27
蔡华容. 糖尿病胃肠道并发症相关研究 [J]. 2018, 13(23):195-196
28
Li YW, Xie CX, Wu KM, et al. Motility characteristics in the transition zone in gastroesophageal reflux disease (GORD) patients [J]. BMC Gastroenterol, 2016, 16(1):106.
29
Deng Y, Pan L, Qian W. Associations between the severity of reflux esophagitis in children and changes in oxidative stress, serum inflammation, vasoactive intestinal peptide and motilin [J]. Exp Ther Med, 2019, 18(5):3509-3513.
30
赵新胜, 买买提·依斯热依力, 克力木·阿不都热依木. 非糜烂性食管炎和内脏高敏感研究新进展[J/OL]. 中华胃食管反流病电子杂志, 2019, 6(4): 211-215.
31
Iwasaki M, Akiba Y, Kaunitz JD. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system [J]. F1000Res,2019, 8:F1000 Faculty Rev-1629.
32
向旭, 朱海杭. 糖尿病并发胃食管反流病患者血浆P物质和血管活性肠肽的水平及意义 [J]. 国际消化病杂志, 2014, 34(4):267-270.
33
Clarrett DM, Hachem C. Gastroesophageal reflux disease (GERD) [J]. Mo Med, 2018, 115(3):214-218.
34
Martin AM, Sun EW, Keating DJ. Mechanisms controlling hormone secretion in human gut and its relevance to metabolism [J]. J Endocrinol, 2019, 244(1):R1-R15.
35
伊力亚尔·麦麦提江, 克力木·阿不都热依木. 胃食管反流病与胰岛素抵抗的研究进展[J/OL]. 中华胃食管反流病电子杂志, 2019, 6(2):106-109.
36
Geysen H, Gielis E, Deloose E, et al. Acute administration of fructans increases the number of transient lower esophageal sphincter relaxations in healthy volunteers [J]. Neurogastroenterol Motil, 2020, 32(1):e13727.
37
Kethman W, Hawn M. New approaches to gastroesophageal reflux disease [J]. J Gastrointest Surg, 2017, 21(9):1544-1552.
38
Chen J, Brady P. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment [J]. Gastroenterol Nurs, 2019, 42(1):20-28.
39
Ha JO, Lee TH, Lee CW, et al. Prevalence and risk factors of gastroesopha geal reflux disease in patients with type 2 diabetes mellitus [J]. Diabetes Metab J, 2016, 40(4): 297-307.
[1] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[2] 贾卓奇, 周维茹, 张勇, 张广健, 付军科. 达·芬奇机器人与腹腔镜食管裂孔疝修补术的对比研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 410-414.
[3] 王竹, 王庚启, 郑军, 端磊, 徐冰, 唐熙晨, 吴泊逸, 王秋根, 王建东, 曹雷, 毕春, 邓国英. 肘关节外侧入路治疗肱骨小头骨折的治疗体会及经验总结[J]. 中华肩肘外科电子杂志, 2023, 11(03): 235-241.
[4] 薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
[5] 陶璐, 初楠, 韩洁, 白春英, 逄雯丽, 余海源. 血清PECAM-1、Sirt1水平与2型糖尿病患者颈动脉粥样硬化的关系[J]. 中华临床医师杂志(电子版), 2023, 17(03): 291-296.
[6] 韩家超, 王飞飞, 柳子宁, 胡冀陶, 孟泽松, 雒月云, 王贵英. 二甲双胍的作用机制研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(03): 349-355.
[7] 王擎, 王冠峰, 陈星. 胃食管阀瓣的Hill分级在胃食管反流病中的应用价值[J]. 中华胃肠内镜电子杂志, 2023, 10(02): 125-130.
[8] 张继舜, 陈思旭, 钱洁, 尚占民, 郝建宇. 平均夜间基线阻抗对食管外症状胃食管反流病的临床诊断价值[J]. 中华胃肠内镜电子杂志, 2023, 10(02): 97-102.
[9] 陆洪鹏, 袁芯, 郑树灏, 刘怡, 徐磊. 慢性咳嗽与胃食管反流病:双向两样本孟德尔随机化研究[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 59-64.
[10] 范勇, 张利昉, 杨美琳. 改良经口内镜下贲门缩窄术治疗胃食管反流病效果分析[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 65-68.
[11] 文明, 熊英, 艾克拜尔·艾力, 克力木·阿不都热依木. 质子泵抑制剂治疗期间焦虑对胃食管反流病疗效的影响[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 90-95.
[12] 李鹏, 刘国祥, 李汝红. 经口内镜下贲门缩窄术治疗胃食管反流病的研究进展[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 96-99.
[13] 买买提·依斯热依力, 尹强, 尹海龙, 董雨微, 王永康, 克力木·阿不都热依木, 阿吉艾克拜尔·艾萨. 传统医药治疗胃食管反流病的研究进展[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 100-104.
[14] 汪赓, 夏泽锋, 陶凯雄. 代谢手术在非肥胖型2型糖尿病中的治疗效果及研究进展[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 155-160.
[15] 李锦亮, 曾茂娟, 钟金宝, 何伟强, 林文新. 司美格鲁肽对肥胖2型糖尿病患者皮肤微循环功能的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 192-196.
阅读次数
全文


摘要